Pacific Blue Cross plan update
The Government of British Columbia and BC PharmaCare have announced the expansion of the use of biosimilars to create new opportunities for new drug listings. Coverage for the original biologic (originator) drugs Remicade, Enbrel, and Lantus, will be discontinued for…